Search tool

Smokable herbal mixtures under the brand name ‘Spice’ are known to have been sold on the Internet and in various specialised shops since at least 2006 and anecdotal reports suggest that those...

This bookmark promotes the EMCDDA’s main output, the Annual report on the state of the drugs problem in Europe. Published every autumn, the report offers a wealth of drug facts, figures and...

Many of the accidents and deaths that occur on European roads are caused by drivers whose performance is impaired by a psychoactive substance. Alcohol alone is estimated to account for up to...

In accordance with Article 76 of the Financial Regulation applicable to the EMCDDA (European Monitoring Centre for Drugs and Drug Addiction), the accounts of the EMCDDA shall comprise: 'The financial statements of...

Drugnet Europe, the EMCDDA's quarterly newsletter, provides regular information on the Agency's activities to a broad readership. In this issue: Brain research throws light on addiction; European action on drugs; Associations between...

This publication is the first in a series dedicated to prevalent illicit synthetic stimulant drugs, also known as amphetamine-type stimulants (ATS). The ATS category is made up of two groups of substances...

This work programme ensures that the EMCDDA remains a key resource for Europe — providing high-quality information to underpin effective drug policies and serving as a catalyst for supporting and developing national...

This report reviews developments in the neuroscience of addiction, explores how they might affect the way we view and treat drug problems, and considers the issues that they raise for drug policy...

The General report of activities is an annual publication providing a detailed progress report of the EMCDDA’s activities over a 12-month period. Published every spring, it catalogues the Centre’s achievements in each...

Drugnet Europe, the EMCDDA's quarterly newsletter, provides regular information on the Agency's activities to a broad readership. In this issue: 15 years of drug monitoring in Europe; new European study on Internet-based...